{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:56:21Z","timestamp":1791867381632,"version":"4.3.4"},"reference-count":57,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R21CA179144"],"award-info":[{"award-number":["1R21CA179144"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Development Research"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>\n<jats:table-wrap position=\"anchor\">\n\n<jats:table frame=\"hsides\">\n<jats:col\/>\n<jats:tbody>\n<jats:tr>\n<jats:td>Preclinical Research<\/jats:td>\n<\/jats:tr>\n<\/jats:tbody>\n<\/jats:table>\n<\/jats:table-wrap><\/jats:p><jats:p>Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm that is frequently characterized by the constitutive expression of the oncogenic protein BCR\u2010ABL tyrosine kinase. Tyrosine kinase inhibitors (TKIs) targeting breakpoint cluster region\u2010ABL are the first\u2010line therapy for most CML patients and have drastically improved the prognosis of CML. However, some CML patients are unresponsive to TKI treatment, and a notable proportion of initially responsive patients develop drug resistance. Several molecular pathways have been correlated with resistance to TKI treatment, however, the exact mechanism of developing drug resistance remains ambiguous. Recently, microRNAs (miRNAs) have been implicated in the progression of CML and the development of resistance to TKI treatment based on their important regulatory function in cell homeostasis, and the deregulation observed in the initiation and progression of many leukemia subtypes. In this review, we summarize some of the major discoveries regarding miRNAs in CML, and their relevance as biomarkers for diagnosis, disease progression, and drug sensitivity. Drug Dev Res 76 : 278\u2013285, 2015. \u00a9 2015 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ddr.21266","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T09:13:09Z","timestamp":1439889189000},"page":"278-285","source":"Crossref","is-referenced-by-count":33,"title":["<scp>miRNAs<\/scp> as Biomarkers in Chronic Myelogenous Leukemia"],"prefix":"10.1002","volume":"76","author":[{"given":"Kasuen","family":"Kotagama","sequence":"first","affiliation":[{"name":"Molecular and Cellular Biology Graduate Program Arizona State University Tempe AZ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung","family":"Chang","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology Graduate Program Arizona State University Tempe AZ USA"},{"name":"Center of Infectious Diseases and Vaccinology, The Biodesign Institute Arizona State University Tempe AZ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mangone","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology Graduate Program Arizona State University Tempe AZ USA"},{"name":"Virginia G. Piper Center for Personalized Diagnostics, The Biodesign Institute Arizona State University Tempe AZ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,18]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-08-0167"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022838"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.461"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.04.018"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.242606799"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq640"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2230"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-197"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2011.01274.x"},{"issue":"3","key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2012.0184","article-title":"Current issues in chronic myeloid leukemia: monitoring, resistance, and functional cure","volume":"10","author":"Cortes J","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2634"},{"key":"e_1_2_7_13_1","first-page":"859","article-title":"A therapeutic improvement: second generation tyrosine kinase inhibitors (TKI 2) in the treatment of chronic myelogenous leukemia","volume":"98","author":"Demarquet M","year":"2011","journal-title":"Bull Cancer"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.007"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12351"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.020636"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-4-r57"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000353391"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701644348"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1064023"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.85"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.10.006"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.02.031"},{"issue":"2","key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"ii63","DOI":"10.1093\/annonc\/mdn091","article-title":"Chronic myelogenous leukemia: ESMO clinical recommendations for the diagnosis, treatment and follow\u2010up","volume":"19","author":"Hochhaus A","year":"2008","journal-title":"Ann Oncol"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2014.03.049"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2138-z"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.08.020"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90529-Y"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2013.02.002"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061858"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2284"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.03.029"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-41"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.13.12.7587"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(03)00552-5"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01630378"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206620"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2009.0065"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-212969"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205029"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/35040556"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510423103"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035501"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-69"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.08.023"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21254"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-011-0139-x"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-169"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-045104"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku626"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2014.02.001"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2014.44"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.557"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/2162-3619-3-17"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.65"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404227"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.066258"}],"container-title":["Drug Development Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fddr.21266","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:16:34Z","timestamp":1760375794000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/ddr.21266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,18]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1002\/ddr.21266"],"URL":"https:\/\/doi.org\/10.1002\/ddr.21266","archive":["Portico"],"relation":{},"ISSN":["0272-4391","1098-2299"],"issn-type":[{"value":"0272-4391","type":"print"},{"value":"1098-2299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,18]]}}}